Market Cap:
$2.4T
2.29%
24h Vol:
$103.6B
87.03%
Dominance:
BTC 56.39%
-0.41%
ETH 9.25%
2.95%

Live ProShares UltraPro QQQ (Ondo Tokenized) (TQQQON) vs Injective Quants (QUNT) Comparison

What would the price and market cap of ProShares UltraPro QQQ (Ondo Tokenized) (TQQQON) be if the market cap of ProShares UltraPro QQQ (Ondo Tokenized) (TQQQON) was equal to the market cap of Injective Quants (QUNT)?

Compare
$
Price of ProShares UltraPro QQQ (Ondo Tokenized) if it had Injective Quants's market cap.
$3.620.04x

Difference between ProShares UltraPro QQQ (Ondo Tokenized) (TQQQON) and Injective Quants (QUNT)

TQQQON Difference QUNT
Market Cap$7,959,84523.04x$345,518
Price$83.42146068.99x$ 0.0005711
Volume (24h)$758,732298.58x$2,541.14
FDV$7,959,84523.04x$345,518
Circulating Supply95,418.516339.30x604,886,557
Total Supply95,418.516339.30x604,886,557
% in Circulation100.00%1.00x100.00%
Max Supply∞-777,777,777
We're committed to your privacy. CryptoCalc uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

ProShares UltraPro QQQ (Ondo Tokenized) or Injective Quants FAQ

Is ProShares UltraPro QQQ (Ondo Tokenized) better than Injective Quants?

Choosing between ProShares UltraPro QQQ (Ondo Tokenized) and Injective Quants depends on their tokenomics metrics, current market trends, your personal goals and how you plan to use cryptocurrency.

At the moment, ProShares UltraPro QQQ (Ondo Tokenized) is priced at $83.42 with a market cap of $7,959,845, while Injective Quants trades around $ 0.0005711 with a market cap of $345,518. In most cases, cryptocurrencies with a lower market cap have higher upside and ROI potential.

To choose an asset that better suits your needs, it’s crucial to consider not only financial metrics but also the technology under cryptocurrency, utilities, community support, and developers' activity.Each has strengths in different areas, so it's best to consider what matters most to you when deciding.

Should I buy ProShares UltraPro QQQ (Ondo Tokenized) or Injective Quants?

When deciding whether to buy ProShares UltraPro QQQ (Ondo Tokenized) or Injective Quants, it's important to compare their current market positions and long-term potential.

Right now, ProShares UltraPro QQQ (Ondo Tokenized) has a market cap of $7,959,845 and a daily trading volume of $758,732, while Injective Quants's market cap is $345,518 with $2,541.14 traded daily. Usually, a coin with lower market cap and higher trading volume has higher potential.

Also, you should consider factors like your risk tolerance, time horizon, and the evolving crypto landscape before making a decision. Research both projects carefully to see which one aligns better with your investment plans.

Should I invest in ProShares UltraPro QQQ (Ondo Tokenized) or Injective Quants?

Choosing whether to invest in ProShares UltraPro QQQ (Ondo Tokenized) or Injective Quants involves understanding their market positions and technological potential. While the latter requires more extensive research, market position can be analyzed based on stats like price, market cap, and FDV.

For example, ProShares UltraPro QQQ (Ondo Tokenized) has a market cap of $7,959,845 with a price of $83.42 and FDV of $7,959,845, while Injective Quants has a market cap of $345,518, FDV of $345,518 and priced at $ 0.0005711. Coins with higher FDV and market cap are more “heavy” in terms of demonstrating wider positive price action. On the contrary, they are more liquid and less volatile, which is better for investing higher capital in them.

As with any investment, past performance does not guarantee future results, so it’s important to make decisions based on thorough research of fundamental factors as well.

What is the difference between ProShares UltraPro QQQ (Ondo Tokenized) and Injective Quants?

The difference between ProShares UltraPro QQQ (Ondo Tokenized) and Injective Quants lies primarily in their design and intended use.

At the same time, ProShares UltraPro QQQ (Ondo Tokenized) holds a market cap of $7,959,845 with circulation supply of 95,418.51 and total supply of 95,418.51, while Injective Quants has a market cap of $345,518 with circulation supply of 604,886,557 and total supply of 604,886,557.

Each project offers unique advantages depending on what you're looking for — whether it's transaction speed, network security, smart contracts, or decentralization. Understanding these distinctions can help you decide which project aligns more closely with your interests.

ProShares UltraPro QQQ (Ondo Tokenized) vs Injective Quants long term

Considering ProShares UltraPro QQQ (Ondo Tokenized) vs Injective Quants for the long term requires examining their roadmaps, market trends, and adoption rates. Other factors that influence the development of any cryptocurrency are tokenomics metrics, the team behind a project, the amount of investments raised, and financial projections.

ProShares UltraPro QQQ (Ondo Tokenized) currently has a market cap of $7,959,845, ATH of $88.20 at 2026-06-03 12:20, and holds market cap rank #1308 while Injective Quants has a market cap of $345,518, ATH of $ 0.0313927 at 2024-11-17 12:50, and holds market cap rank #3985. The rule is the following: the lower the market cap, FDV and market cap rank, the greater growth upside a coin has. However, higher market cap, FDV and market cap rank mean that a coin is more liquid, popular and secure as a store of value.

Future success could depend on technology updates, regulatory acceptance, and real-world use case growth. Long-term performance will likely be influenced by ecosystem expansion, developer activity, and macroeconomic factors.

LogoFollow usX SocialTelegram Social
Subscribe to our Newsletter
We're committed to your privacy. CryptoCalc uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.
© 2026 CryptoCalc. All rights reserved.